Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTR9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,116
Award facts
- Contract value 100% obligated
- $7,116.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,116.09 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—to support military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's substantial role in the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FXTR9?
SPE2DR26FXTR9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FXTR9 worth?
The government has obligated $7,116 on SPE2DR26FXTR9.
Is contract SPE2DR26FXTR9 an order under another contract?
Yes. SPE2DR26FXTR9 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTR9 competed?
The extent of competition for SPE2DR26FXTR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award